| TC | Stat | Stk | Ins | Fil | +d | +w | +m | +q | +h | +y | avg | 
|---|
| Filing Date | T Date | Ticker | Issuer | Inc | Sector | Ind | Industry | Owner | oSt | Rel | Title | T | TVal | Price | L | Qty | oc | Own | H | r2y | r1y | r6m | r3m | r6w | r3w | r7d | r3d | f1d | f1w | f1m | f3m | f6m | f1y | 
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 12/20/24 20:00 | 12/19/24 | THAR | Tharimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milby Randy | NJ | DO | CEO | P | 10 | 2.12 | 0 | 5 | 36 | 18 | D | ||||||||||||||
| 10/10/24 16:15 | 10/8/24 | THAR | Tharimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milby Randy | NJ | DO | CEO | P | 5 | 2.09 | 0 | 3 | 24 | 13 | D | ||||||||||||||
| 12/18/23 10:04 | 12/15/23 | THAR | Tharimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milby Randy | NJ | DO | CEO | P | 15 | 0.5030 | 0 | 29 | 23 | 157 | D | ||||||||||||||
| 12/4/23 16:15 | 11/30/23 | THAR | Tharimmune, Inc. | DE | Health | Drug | Pharmaceutical Preparations | Milby Randy | NJ | DO | CEO | P | 10 | 1.00 | 0 | 10 | 9 | 128 | D | 
| D | Derivative transaction in filing (usually option exercise) | 
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price | 
| A | Amended filing | 
| E | Error detected in filing | 
| S - Sale | Sale of securities on an exchange or to another person | 
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) | 
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company | 
| P - Purchase | Purchase of securities on an exchange or from another person |